Skip To Main Content
Michael Blaiss on Muck Rack

Michael Blaiss

River Oaks
As seen in: MSN, Wiley Online Library, Aol, Frontiers, U.S. News and World Report, JAMA (The Journal of the American Medical Association), Everyday Health, Healio, Healio Allergy/Asthma, The Journal of Allergy & Clinical Immunology and
Allergist, Executive Medical Director of the American College of Allergy, Asthma, and Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sublingual immunotherapy effective for young children with allergic rhinitis

|
By Richard Gawel Verified, Kristen Dowd Verified, Michael Blaiss, Nikhila D Schroeder
| Healio Allergy/Asthma Verified
Perspective Back to Top Michael S. Blaiss, MD, FACAAI, FAAAAI These findings are not surprising, as we see the same efficacy and safety in the population aged 12 years and older in the United States with the FDA-approved HDM SLIT tablet. Nevertheless, these results are from a small number of subjects that was not randomized and placebo-controlled, so we should understand that it was not a rigorous study.
Open in Who Shared Issue with article?

Subcutaneous allergen immunotherapy reduces asthma risk, improves symptom control

|
By Victoria Langowska, Kristen Dowd Verified, Michael Blaiss
| Healio Allergy/Asthma Verified
Michael S. Blaiss, MD, FACAAI, FAAAAI The findings from this real-world data Germany study confirm previous studies that subcutaneous allergen immunotherapy with house dust mite can lead to immunomodulation and decrease the need for AR treatment and the development or time of onset of asthma. It is important to note that in this study that a house dust mite depot immunotherapy containing aluminum hydroxide was used that is not available in the United States.
Open in Who Shared Issue with article?

Quality of life improves with sublingual immunotherapy for patients with allergic rhinitis

|
By Richard Gawel Verified, Kristen Dowd Verified, Michael Blaiss
| Healio Allergy/Asthma Verified
You've successfully added Food Allergy to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Key takeaways: The review included 11 trials and more than 6,000 patients. Improvements included symptoms, sleep, emotions, problems and activities. Scores remained significant after accounting for age and sex.
Open in Who Shared Issue with article?
See all 88 licensed articles (89 Total)